These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21707454)

  • 21. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced ovarian cancer detection. Two-test combo may identify disease early enough to cure it.
    Duke Med Health News; 2009 Jun; 15(6):8-9. PubMed ID: 19575525
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower genital tract metastases at time of first diagnosis of mammary invasive lobular carcinoma.
    Engelstaedter V; Mylonas I
    Arch Gynecol Obstet; 2011 Mar; 283 Suppl 1():93-5. PubMed ID: 21293870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast mass in a patient with ovarian cancer: a case report.
    Gayathri S; Badve S; Matei D
    J Reprod Med; 2009 Oct; 54(10):639-44. PubMed ID: 20677485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peritoneal carcinomatosis].
    Coelho SS; Silva PM; Ramos J
    Acta Med Port; 1998 Jun; 11(6):585-9. PubMed ID: 9773541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucinous carcinoma of the ovary as a source of peritoneal mucinous carcinomatosis.
    Srinivasan R; Menezes RG; Mamata S
    Indian J Pathol Microbiol; 2010; 53(2):387. PubMed ID: 20551576
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening of symptomatic women for ovarian cancer.
    Tone AA; Huntsman DG; Miller DM
    Lancet Oncol; 2012 Apr; 13(4):e137-8; author reply e139-40. PubMed ID: 22469120
    [No Abstract]   [Full Text] [Related]  

  • 30. Screening of symptomatic women for ovarian cancer.
    Crum CP
    Lancet Oncol; 2012 Apr; 13(4):e137; author reply e139-40. PubMed ID: 22469119
    [No Abstract]   [Full Text] [Related]  

  • 31. Early detection of ovarian cancer in symptomatic women.
    van Nagell JR
    Lancet Oncol; 2012 Mar; 13(3):223-4. PubMed ID: 22257525
    [No Abstract]   [Full Text] [Related]  

  • 32. Ovarian cancer: real progress in early detection.
    Johns Hopkins Med Lett Health After 50; 2005 Jan; 16(11):3, 7. PubMed ID: 15693151
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnostic dilemma in an elderly woman with intractable ascites and elevated CA-125 level.
    Gupta S; Maheshwari A; Wuntkal R; Mazid T; Tongaonkar HB
    J Assoc Physicians India; 2006 Aug; 54():655-6. PubMed ID: 16941798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. By the way, doctor. I received a widely circulated e-mail message about use of the CA-125 blood test in screening for ovarian cancer. The message suggested that the CA-125 test be used for routine screening, like a Pap smear. Do you agree? What's your opinion of this test?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Jul; 8(11):8. PubMed ID: 11511469
    [No Abstract]   [Full Text] [Related]  

  • 35. Ovarian cancer screening.
    Eason EL
    CMAJ; 2005 Feb; 172(4):447. PubMed ID: 15710918
    [No Abstract]   [Full Text] [Related]  

  • 36. CA-125 and early ovarian cancer: does this help the clinician or further muddy the water?
    McGuire WP
    J Clin Oncol; 2005 Sep; 23(25):5862-4. PubMed ID: 16087955
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum CA-125 screening for ovarian cancer in patients with dermatomyositis.
    Whitmore SE; Anhalt GJ; Provost TT; Zacur HA; Hamper UM; Helzlsouer KJ; Rosenshein NB
    Gynecol Oncol; 1997 May; 65(2):241-4. PubMed ID: 9159332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.